Literature DB >> 25150443

Label-free mass spectrometric profiling of urinary proteins and metabolites from paediatric idiopathic nephrotic syndrome.

Mirela Sedic1, Lee A Gethings2, Johannes P C Vissers2, John P Shockcor3, Stephen McDonald3, Olga Vasieva4, Maja Lemac5, James I Langridge2, Danica Batinić5, Sandra Kraljević Pavelić6.   

Abstract

Idiopathic nephrotic syndrome (INS) is caused by renal diseases that increase the permeability of the glomerular filtration barrier without evidence of a specific systemic cause. The aim of the present work was to reveal inherent molecular features of INS in children using combined urinary proteomics and metabolomics profiling. In this study, label-free mass spectrometric analysis of urinary proteins and small molecule metabolites was carried out in 12 patients with INS versus 12 sex- and age-matched control subjects with normal renal function. Integration and biological interpretation of obtained results were carried out by Ingenuity IPA software. Validation of obtained proteomics data was carried out by Western blot method. Proteomics data have been deposited to the ProteomeXchange Consortium with the data set identifier PXD000765. This study indicates for the first time that paediatric INS is associated with up-regulation of afamin, hydroxyphenylacetate and uridine, and concomitant down-regulation in glutamine and phenylalanine levels, and many of these molecular species were previously shown to be involved in oxidative stress. Further studies in larger patient population are underway to investigate the role of oxidative stress in renal injury in paediatric INS.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Afamin; Metabolomics; Oxidative stress; Pediatric nephrotic syndrome; Proteomics; Urine

Mesh:

Year:  2014        PMID: 25150443     DOI: 10.1016/j.bbrc.2014.08.016

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus.

Authors:  Rita Kansal; Noah Richardson; Indira Neeli; Saleem Khawaja; Damian Chamberlain; Marium Ghani; Qurat-Ul-Ain Ghani; Louisa Balazs; Sarka Beranova-Giorgianni; Francesco Giorgianni; James N Kochenderfer; Tony Marion; Lorraine M Albritton; Marko Radic
Journal:  Sci Transl Med       Date:  2019-03-06       Impact factor: 17.956

2.  Quantitative mass spectrometry of urinary biomarkers.

Authors:  Marina Jerebtsova; Sergei Nekhai
Journal:  J Integr OMICS       Date:  2014-12-01

3.  Gene Expression Studies and Targeted Metabolomics Reveal Disturbed Serine, Methionine, and Tyrosine Metabolism in Early Hypertensive Nephrosclerosis.

Authors:  Marius A Øvrehus; Per Bruheim; Wenjun Ju; Leila R Zelnick; Knut A Langlo; Kumar Sharma; Ian H de Boer; Stein I Hallan
Journal:  Kidney Int Rep       Date:  2018-10-17

4.  Integrated Metabolomics and Network Pharmacology to Establish the Action Mechanism of Qingrekasen Granule for Treating Nephrotic Syndrome.

Authors:  Yanfen Duan; Dongning Zhang; Yan Ye; Sili Zheng; Ping Huang; Fengyun Zhang; Guoyan Mo; Fang Huang; Qiang Yin; Jingjing Li; Lintao Han
Journal:  Front Pharmacol       Date:  2021-12-06       Impact factor: 5.810

Review 5.  Contribution of Metabolomics to Multiple Sclerosis Diagnosis, Prognosis and Treatment.

Authors:  Marianna Gabriella Rispoli; Silvia Valentinuzzi; Giovanna De Luca; Piero Del Boccio; Luca Federici; Maria Di Ioia; Anna Digiovanni; Eleonora Agata Grasso; Valeria Pozzilli; Alessandro Villani; Antonio Maria Chiarelli; Marco Onofrj; Richard G Wise; Damiana Pieragostino; Valentina Tomassini
Journal:  Int J Mol Sci       Date:  2021-10-15       Impact factor: 5.923

Review 6.  Biomarkers in pediatric glomerulonephritis and nephrotic syndrome.

Authors:  Gabriel Cara-Fuentes; William E Smoyer
Journal:  Pediatr Nephrol       Date:  2021-01-03       Impact factor: 3.714

7.  Urine proteomics of primary membranous nephropathy using nanoscale liquid chromatography tandem mass spectrometry analysis.

Authors:  Lu Pang; Qianqian Li; Yan Li; Yi Liu; Nan Duan; Haixia Li
Journal:  Clin Proteomics       Date:  2018-02-07       Impact factor: 3.988

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.